This double-blind prospective study was designed to determine the best dose variables for patient-controlled epidural analgesia (PCEA) 
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When we lose control over our environment and our body, pain tolerance and perception are adversely affected. 1 In hospital, parturients experience a loss of control, to some extent, in privacy, mobility, bodily functions and choice. With the advent of patient-controlled analgesia (PCA), some control has been returned to patients which has increased their satisfaction with pain relief. Previous studies have shown that application of PCA to epidural analgesia in labour allows parturients to titrate adequate and satisfactory analgesic levels on demand. 2-6,8-~1 Dosing delays are avoided which decreases the feed-back loop. Self-administration of small increments of dilute local anaesthetic is more likely to avoid the adverse consequences of large bolus administration.
Patient-controlled epidural analgesia (PCEA) is versatile, effective and associated with high patient satisfaction. 2'6'1~ In addition, it is safe and is associated with lower local anaesthetic requirements than continuous infusion epidural analgesia (CIEA). 2,4 The efficacy of PCEA is due to prompt administration of drug and the alleviation of anxiety often associated with the anticipation of a return of pain. The concept of patient-control is easily understood and well accepted by most parturients.
To date, dosing variables for PCEA have been arbitrarily selected. This study was designed to determine the optimal initial combination of bolus dose and lockout interval. It was decided that any dose combination would be deemed superior if associated with greater analgesia, improved patient satisfaction, lower sensory levels or a success: total PCA demand ratio close to 1.0. At the same time, bolus-only PCEA was compared in a double-blind fashion with CIEA.
Methods
The study was approved by the hospital and university research committees. Informed consent was obtained from each parturient. Nulliparous, ASA I or II, Englishspeaking parturients with uncomplicated, singleton pregnancies, 18 yr or more, in established labour and requesting epidural analgesia were recruited. Women with severe medical or obstetric complications, multiple gestation, contraindication to epidural analgesia, local anaesthetic or fentanyl allergy, were excluded from the study. TABLE I Study groups 2 ml bolus/10 min lockout 3 ml bolus/15 min lockout 4 ml bolus/20 min lockout 6 ml bolus/30 min lockout 8 ml/hr continuous infusion Analgesic mixture for each group was: bupivacaine 0.125% + 1:400,000 epinephrine + fentanyl 2.5 ~g" ml-k Each parturient received 500-1000 ml NaC1 0.9%/v prior to initiating epidural blockade. Epidural catheter placement was performed in a standard manner and all patients were given an initial dose of 8-10 ml bupivacaine 0.25%.
Patients were instructed in the use of the Bard PCA | pump and then randomly assigned to one of five groups (Table I) . Each group received bupivacaine 0.125% with 1:400,000 epinephrine and fentanyl 2.5 Ixg" ml-i through the pump.
An infusion rate of 8 ml-hr -l was selected for CIEA (Group E) because it is an infusion rate commonly used in our institution. The PCA demand button was used, but made inactive for these patients. The study protocol allowed for changing the infusion rate in order to maintain the sensory level between Tl0 and T6.
Both patient and investigator were unaware of the group assignment. The PCA pump was programmed by a second investigator after referring to a previously constructed randomisation table. All patients, including those in Group E, were told to press the demand button when pain returned and to expect some relief within five to ten minutes. Supplemental epidural analgesia was provided if patients failed to get adequate pain relief after 30 min despite making numerous demands in that time. Additional boluses of bupivacaine (0.125-0.5%) were used to overcome inadequate sensory levels and fentanyl (25-100 ~g) was given for back pain and/or perineal discomfort, in the presence of bilateral Tl0 sensory levels. If these supplements were inadequate a full "top-up" dose of 12 ml bupivacaine 0.125% with 1:800,000 epinephrine was injected. If this was unsuccessful the patient was removed from the study.
The study began when the PCA pump was attached to the epidural catheter and ended with the onset of the second stage. Every hour, a blinded investigator collected the following data: 10 cm VAS scores for pain, satisfaction, maximum pain/minimum satisfaction in the preceding hour, sensory levels (using ice), motor block, maternal BP and fetal heart rate (FHR). Other data included hourly bupivacaine and fentanyl requirements including all supplements but excluding the initial dose of bupivacaine 0.25%; the ratio of successful to total PCA demands; duration and outcome of labour; one and five min Apgar scores; and a global evaluation of analgesia and satisfaction by patient and investigator following completion of the study. All VAS levels were converted into pain relief and satisfaction indices which represented a % change from the baseline score. Percentage pain relief (PPR) is 100 minus [(measured VAS + pre-epidural VAS) )< 100]. A high PPR represents excellent analgesia, while a low PPR represents inadequate analgesia. This applies equally to satisfaction score (SS).
Plasma fentanyl concentrations were measured on maternal venous and umbilical artery samples taken at delivery. An enzyme-linked immunoabsorbent assay (ELISA) was performed using a kit produced by Kentucky Technology Inc, at the CanTest laboratories in Vancouver. This assay measured concentrations of fentanyl and its metabolite. Average absorbency was plotted against fentanyl concentration with a correlation coefficient equal to 0.99.
Statistical analysis of data was performed using Chisquare analysis, a series of one-way analyses of variance to compare all groups at each time and repeated measures analysis of Variance to consider all time points in a single analysis. Demographic data were compared using oneway analysis of variance. Total analgesic supplements across groups were compared using Chi-square goodness of fit tests. A P-value < 0.05 was considered to be statistically significant. All groups were compared independently but for the purposes of comparing PCEA with CIEA, data from groups A-D inclusive were also compared with Group E alone. Our sample sizes gave 80% power with 15 patients in each group in order to detect changes of the following magnitudes: a difference in VAS score of 2 (with a SD of 2) between two groups; a 2-segment difference in sensory level; a difference of 0.3 in PCA (success:total) demand ratio. These values were chosen in order to detect what would, in our opinion, be clinically important differences.
Results
Seventy-five patients were recruited to the study but data from only 68 were analysed. Four patients were excluded because of incomplete data; one had a blocked epidural catheter; one had inadequate analgesia from the initial dose and the last was withdrawn at her own request after she had failed to use the pump as instructed.
All five groups consisted of patients similar in terms of age, height, weight, study duration and cervical dilatation prior to epidural insertion (Table II) .
There were no differences among groups in terms of pain relief or patient satisfaction throughout the study. Bupivacaine and fentanyl consumption were less in Groups A-D inclusive than in Group E, whether compared individually or combined (Figures 2a and 2b ).
There were no differences among any of the PCEA groups in this regard. In Group E, bupivacaine consumption, mean (SD), was 9.4 (2.7) vs 5.2 (1.7) mg-hr -l for Groups A-D combined, P < 0.0001.
In Group E, fentanyl consumption was 19.6 (4.6) vs 12.6 (7.5) I~g" hr -] for Groups A-D combined; P < 0.05.
Sensory levels were similar among groups, except at the third and fourth hourly intervals, where higher levels were seen in both Groups D and E than in all other groups (Figure 3) .
Motor block was minimal in all patients, with no differences among groups (Table III) .
There was no maternal hypotension or fetal bradycardia associated with PCA use.
All four PCEA groups (A-D) had similar ratios of successful:total PCA demands; range (mean ___ SD) = 0.41 ___ 0.26 to 0.63 • 0.22.
There were no differences among groups in terms of the number of bupivacaine or fentanyl epidural supplements for inadequate analgesia (Table IVa and b) . Seventy-five percent of those patients requiring a supplement received just one dose throughout the study. The timing of its administration was not related to the duration of the study, although full "top-up" doses were often given during transition into second stage or for unilateral block. The number of full "top-ups" did not vary among groups. Out of 68 patients, a total of 13 full "topup" supplements were given (19%), with a range of 1-4 full "top-ups" across groups. Delivery type and neonatal outcome are described in Table V . The spontaneous vaginal delivery rate was less in Group E than Groups A-D combined, 21% vs 51%, (P < 0.5, Chi-square).
Three neonates required resuscitation at birth for low Apgar scores and meconium present at delivery. All were easily treated, using suction below the cords and IPPV with 100% oxygen for 30-60 secs. Each had a good outcome with normal five minute Apgar scores. There was no correlation between low one minute Apgar scores and umbilical artery fentanyl concentrations (all were <0.1 ng" ml-l).
No patient had a fentanyl concentration >0.5 ng" ml -~ in maternal or umbilical samples and there was no correlation between total fentanyl consumption or time of last fentanyl dose and the plasma concentration. Seventy percent of all samples had a fentanyl concentration <0.1 ng. ml -l and there were no differences in plasma fentanyl concentrations among groups.
After completion of the study both patient and investigator evaluated efficacy of the technique using a five point scale (poor, fair, good, very good, excellent). All evaluations were rated good to excellent with no difference among groups.
Discussion
This study asked the following questions: (1) Does it matter which PCA dose variables are used to set up PCEA in labour? (2) Is PCEA, without a background infusion, as effective as CIEA?
The results showed no differences among any of the PCEA groups, except that Group D patients, who received the largest bolus size with each patient administration, had higher sensory levels than the others at three and four hours into the study. No adverse sequelae were seen, such as maternal hypotension or fetal bradycardia, as a result of this observed difference. In addition, the incidence of motor block was similar in all four PCEA groups.
The number of analgesic supplements of either epidural fentanyl or bupivacaine was the same in all four groups. The percentage of patients receiving either a bupivacaine or fentanyl supplement ranged from a high of 50% in Group A to a low of 28.6% in Group B (P = NS); see Table IV . Overall, 37% of all parturients receiving PCEA required additional supplementary boluses, which is comparable with the 34% reported by Paech in a previous study. 5 If every PCA demand had resulted in successful administration then the success:total ratio would be 1.0. In Group A this ratio was highest at 0.64 and in Group D lowest at 0.41 (P = NS). This ratio may not only reflect efficacy of the combination of dose variables, but also differences in the way PCA is used by parturients. Some press the demand button at the slightest provocation while others make only a few demands each hour. In the long run, patients are satisfied with the technique irrespective of their pattern of PCA use.
All PCEA groups experienced the same degree of analgesia and satisfaction, with comparable bupivacaine and fentanyl consumption. Patients in Group E, however, used more bupivacaine and fentanyl throughout the study than Groups A-D, alone or in combination. This finding is in keeping with other reports which have shown that PCEA is associated with a dose-sparing effect compared to continuous epidural infusion. 2, 4, 5 This finding is even more pronounced when there is no background or basal infusion used with PCEA. Our results have shown that bolus-only PCEA is as effective as CIEA, with 45% less bupivacaine and 36% less fentanyl consumption in the PCEA groups combined. The redundancy of a background infusion with PCEA has also been shown in studies by EelTante 4 and Paech. 5 Ferrante demonstrated a 47% dose-sparing of bupivacaine and a 55% sparing of fentanyl when "demand-dosing" PCEA was compared to CIEA. Paech showed a dose-sparing of fentanyl, but not bupivacaine, in those patients receiving PCEA without a basal infusion. Degree of analgesia, maternal satisfaction and side effects were similarly unaffected by the addition of a basal infusion. Similar conclusions were made in another study, which compared bolus-only PCEA with intermittent "top-up" injections by an anaesthetist. 6 Each of these reports confirrn the study by Owen et al. who administered intravenous PCA with a concurrent infusion. 7 An arbitrarily selected basal rate, over which the patient has no control, compromises the theoretical advantages of PCA. The patient can no longer tailor the administration of analgesia to her needs, because of an additional factor over which she has no control. This is particularly important with the/v technique because insidious opioid overdose is possible in some patients. Owen summed it up by stating that "... addition of mandatory infusion to PCA not only fails to improve the efficacy but it also reduces (its) inherent safety ...'. 7
Our present study has shown that CIEA, using bupivacaine 0.125% with epinephrine and fentanyl, was associated with a lower rate of spontaneous vaginal delivery (SVD) than all PCEA groups combined. This has not been observed in other studies. There are many factors which can affect SVD rate but cannot be controlled. Our observation does not imply a cause and effect relationship between CIEA and lower rates of SVD. A study with larger numbers would be needed to confirm this finding.
High patient satisfaction was reported by most patients in this study either by VAS scores or by the global evaluation completed at the end of the study. Group E patients were no different. This may have been due to the double-blind nature of the study and the intrinsic placebo effect of PCEA.2 Previous studies of PCEA have also demonstrated high patient acceptance and satisfaction, making this technique an increasingly popular method of labour analgesia. 8-n Whereas we did not study the effect of PCEA during the second stage of labour, in practice most parturients using PCEA are advised to self-administer doses throughout the second stage. This is in contrast to the usual practice of many birth attendants, who are reluctant to give further doses during the second stage, out of concern for prolonging its course and increasing the risk of instrumental delivery. Ferrante demonstrated that second stage use of PCEA did not adversely influence delivery. There was a 90% SVD rate in his study. 4 Patient-controlled epidural analgesia provides a means of comparing one local anaesthetic with another, in various concentrations with or without different opioid supplements. The addition of fentanyl 2.5 ~tg. rnl -~ to bupivacaine 0.125% with 1:400,000 epinephrine resulted in measurable levels of fentanyl in the plasma of some sampies. No patient suffered sequelae from fentanyl apart from mild pruritus. All fentanyl concentrations were _<0.5 ng. m1-1, corresponding to the lower levels of the minimum effective analgesic concentration (MEAC) for fentanyl. ~2 Respiratory depression in the neonate is usu-ally associated with a plasma fentanyl concentration > 1.0 ng. ml -l. 13 Another method by which we might have assessed PCEA variables is to alter dose volume while keeping lockout time constant. Alternatively the lockout time can be varied using a constant dose volume. Although we considered these options, we elected to allow parturients access to a guaranteed maximum hourly volume through the PCA pump. In a recent study by Purdie et al., 1o the parturient had access to all doses in the fast 20 min rather than spacing the doses evenly throughout the hour (e.g., 4 ml dose q 5 min with an hourly maximum of 16 ml). Past studies have used evenly spaced doses. A future study of these two dosing patterns might shed light on which is superior.
In summary, there were no differences seen among the four dosing programmes chosen for PCEA in labour. Patients in each group experienced similar degrees of satisfactory pain relief, and this was comparable to the analgesia provided by constant infusion. All PCEA groups had lower bupivacaine and fentanyl consumption than with continuous infusion. The PCEA was associated with a higher spontaneous delivery rate than CIEA, but management of second stage of labour was not standardized. No parturient or newborn had a clinically important serum fentanyl concentration. Bolus-only PCEA using bupivacaine 0.125% with 1:400,000 epinephrine and fentanyl 2.5 Isg" ml -~ is a safe and effective technique regardless of which initial dose and lockout interval is programmed. Reasonable hourly maximum doses should not be exceeded and minimum effective hourly doses should be guaranteed.
